Active Ingredient History
Glycerin (glycerol) is 3-carbon alcohol naturally occurring in the human body. It is the structural backbone triacylglycerol molecules, and can also be converted to a glycolytic substrate for subsequent metabolism. Glycerin is a colorless, odorless, viscous, sweet-tasting liquid. The FDA classifies glycerol as "generally recognized as safe". Glycerin is used in the pharmaceutical industry as a sweetener in syrups, lozenges, and as an excipient in eyewash solutions. As an individual prescription product, glycerin has uses as a hyperosmotic, osmotic diuretic, and ophthalmic agent. It may be used as an eye drop in the treatment of glaucoma to reduce intraocular pressure, as a solution or suppository for short-term treatment of constipation, to evacuate the bowel prior to a colonoscopy, and in some ocular surgeries. It may be given intravenously to reduce pressure inside the brain and used externally on the skin as a moisturizer. Glycerin has many other uses in the agricultural, food and pharmaceutical industry. NCATS
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Combination drugs
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Breast Neoplasms (Phase 2)
Cataract (Phase 4)
Constipation (Phase 3)
Coronavirus Infections (Phase 2)
COVID-19 (Phase 2)
Dentin Sensitivity (Phase 4)
Dermatitis, Atopic (Phase 3)
Dermatitis, Contact (Phase 4)
Dermatitis, Occupational (Phase 4)
Dermatology (Phase 2)
Disease Progression (Phase 4)
Dry Eye Syndromes (Phase 4)
Exanthema (Phase 2)
Eye Diseases (Phase 4)
Fecal Incontinence (Phase 4)
Food Hypersensitivity (Phase 2)
Gastroschisis (Phase 4)
Headache Disorders (Phase 1/Phase 2)
Hearing Loss (Phase 4)
Hysterectomy (Phase 4)
Keratoconjunctivitis Sicca (Phase 4)
Lacrimal Apparatus Diseases (Phase 2)
Meningitis, Bacterial (Phase 3)
Nails, Malformed (Phase 3)
Neurogenic Bowel (Phase 4)
Obesity, Abdominal (Phase 4)
Otitis (Phase 4)
Otitis Media (Phase 3)
Pain, Postoperative (Phase 4)
Pancreatitis (Phase 4)
Parenteral Nutrition (Phase 4)
Peanut Hypersensitivity (Phase 2)
Pharyngeal Diseases (Phase 2)
Postmenopause (Phase 2)
SARS-CoV-2 (Phase 2)
Severity of Illness Index (Phase 4)
Skin Aging (Phase 4)
Skin Diseases (Phase 1/Phase 2)
Staining and Labeling (Phase 4)
Survivors (Phase 2)
Tears (Phase 4)
Trigeminal Neuralgia (Phase 1/Phase 2)
Vaginal Diseases (Phase 2)
Vertigo (Phase 4)
Virus Diseases (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
